Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients

Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients https://t.co/7pfbu4Tqoq

Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients https://t.co/gQUEKnoced https://t.co/IpLuXFmvhP

New research: Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients: Background Although rare, ERBB2 exon 16 skipping mutations (ERBB2ΔEx16) have been implicated in… https://t.co/PK2lc